K, H., H, U., N, K., M, M., F, Y., G, S., . . . T, H. (2021). Pre-Existing Diabetes Limits Survival Rate After Immune Checkpoint Inhibitor Treatment for Advanced Lung Cancer: A Retrospective Study in Japan [Corrigendum]. Dove Medical Press.
Style de citation Chicago (17e éd.)K, Hisanaga, et al. Pre-Existing Diabetes Limits Survival Rate After Immune Checkpoint Inhibitor Treatment for Advanced Lung Cancer: A Retrospective Study in Japan [Corrigendum]. Dove Medical Press, 2021.
Style de citation MLA (8e éd.)K, Hisanaga, et al. Pre-Existing Diabetes Limits Survival Rate After Immune Checkpoint Inhibitor Treatment for Advanced Lung Cancer: A Retrospective Study in Japan [Corrigendum]. Dove Medical Press, 2021.
Attention : ces citations peuvent ne pas être correctes à 100%.